Explore
Validate
LearnGTX100276
antibody from GeneTex
Targeting: FOXM1
FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident
Western blot
Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GTX100276 - Provider product page
- Provider
- GeneTex
- Proper citation
- GeneTex Cat#GTX100276, RRID:AB_1240833
- Product name
- FOXM1 antibody [C3], C-term
- Antibody type
- Polyclonal
- Reactivity
- Human
- Host
- Rabbit
Submitted references ITR‑284 modulates cell differentiation in human chronic myelogenous leukemia K562 cells.
Identification of neuron selective androgen receptor inhibitors.
FOXM1 binds directly to non-consensus sequences in the human genome.
Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.
Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.
Yang JS, Lee CY, Cho HC, Lu CC, Kuo SC, Wen YF, Tsai FJ, Lee MR, Tsai SC
Oncology reports 2018 Jan;39(1):383-391
Oncology reports 2018 Jan;39(1):383-391
Identification of neuron selective androgen receptor inhibitors.
Otto-Duessel M, Tew BY, Vonderfecht S, Moore R, Jones JO
World journal of biological chemistry 2017 May 26;8(2):138-150
World journal of biological chemistry 2017 May 26;8(2):138-150
FOXM1 binds directly to non-consensus sequences in the human genome.
Sanders DA, Gormally MV, Marsico G, Beraldi D, Tannahill D, Balasubramanian S
Genome biology 2015 Jun 23;16:130
Genome biology 2015 Jun 23;16:130
Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.
Ju SY, Huang CY, Huang WC, Su Y
Cell death & disease 2015 Jul 2;6(7):e1801
Cell death & disease 2015 Jul 2;6(7):e1801
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.
Bergamaschi A, Madak-Erdogan Z, Kim YJ, Choi YL, Lu H, Katzenellenbogen BS
Breast cancer research : BCR 2014 Sep 12;16(5):436
Breast cancer research : BCR 2014 Sep 12;16(5):436
Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
Chen PM, Cheng YW, Wang YC, Wu TC, Chen CY, Lee H
Neoplasia (New York, N.Y.) 2014 Nov;16(11):961-71
Neoplasia (New York, N.Y.) 2014 Nov;16(11):961-71
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.
Sanders DA, Ross-Innes CS, Beraldi D, Carroll JS, Balasubramanian S
Genome biology 2013 Jan 24;14(1):R6
Genome biology 2013 Jan 24;14(1):R6
No comments: Submit comment
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- FOXM1 antibody [C3], C-term detects FOXM1 protein by western blot analysis.A.30 ?g 293T whole cell lysate/extractB.30 ?g whole cell lysate/extract of human FOXM1-transfected 293T cells7.5% SDS-PAGEFOXM1 antibody [C3], C-term (GTX100276) dilution: 1:5000 The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Non-transfected (¡V) and transfected (+) 293T whole cell extracts (30 ?g) were separated by 7.5% SDS-PAGE, and the membrane was blotted with FOXM1 antibody [C3], C-term (GTX100276) diluted at 1:5000.
Supportive validation
- Submitted by
- GeneTex (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of paraffin-embedded human ovarian cancer, using FOXM1(GTX100276) antibody at 1:100 dilution.
